Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Surg Case Rep ; 113: 109060, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37979555

ABSTRACT

INTRODUCTION: Tuberous sclerosis complex (TSC) is an autosomal dominant disease that affects multiple organs. Medical therapy with the mTOR inhibitor everolimus has become the first option in patients with angiomyolipomas. But mTOR inhibitor treatment shows no effect in some patients, in the case, surgery is a suitable method for treatment. PRESENTATION OF CASE: A 30-year-old Chinese male patient received an ultrasound examination of the kidney, which showed bilateral hyperechogenic structures without stones or ureterohydronephrosis. A computed tomography (CT) scan of the kidneys showed multiple slightly high-density masses (largest size: left 6.5 cm, right 5.2 cm), and the masses lacking of lipids were obviously enhanced in the arterial phase. To clarify the components of the tumors, we performed retroperitoneal laparoscopic tumor enucleation to remove all visible masses in left kidney. The pathological results and genetic tests confirmed the diagnosis of TSC. For reducing the further spontaneously bleeding risk and the cost burden, the right renal tumors were also enucleated. Twelve months after the second operation, renal function remained normal, and no tumors were detected by CT. DISCUSSION: Large angiomyolipomas (>4 cm in diameter) may develop life-threatening hemorrhage or compress normal kidney tissue. Fat-poor renal angiomyolipomas are difficult for making a differential diagnosis from renal cancer or renal sarcomatoid carcinoma. When medication treatment does not work, surgery is a good option to diagnose and treat big bilateral renal angiomyolipomas. CONCLUSION: After 12 months of follow-up, retroperitoneal laparoscopic tumor enucleation may be a safe and effective method for treating big fat-poor renal angiomyolipomas in patients with TSC.

2.
Saudi J Biol Sci ; 28(12): 7077-7081, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34867009

ABSTRACT

Daidzin, 4', 7-dihydroxyisoflavone is an isoflavonic phytoestrogen present in leguminous plants. Traditional Chinese medicine utilizes daidzin to treat various diseases such diarrhea, fever, hepatitis, cardiac problems etc. In current study we examined the anticancer activity of daidzin against human cervical cancer in vitro. HeLa, human cervical cancer cell line was purchased from ATCC and the cells were cultured with DMEM medium. The cytotoxic effect of daidzin against HeLa cell line was analyzed with MTT assay. The IC-50 value was obtained at 20 µM hence the cells were treated with 20 µM of daidzin for further analysis. ROS generation was assessed with DCFH-DA staining and the induction of apoptosis was examined with Rhoadmine-123 staining. Acridine orange and ethidium bromide staining was done to examine the apoptotic and viable cells. Further the matrigel cell adhesion assay was done to analyze the inhibitory property of daidzin against cancer cell adhesion. Apoptotic induction of daidzin was examined by estimating the levels of Caspase 8 & 9 using ELISA technique. Inflammatory and cell proliferation signaling proteins were analyzed with qPCR analysis to confirm the anticancer activity of daidzin against human cervical cancer HeLa cell line. Daidzin significantly generated ROS and altered the mitochondrial membrane permeability in HeLa cell line. The results of AO/EtBr staining prove daidzin induced apoptosis in HeLa cell line and it also inhibited the cell adhesion property of HeLa which is reported in our matrigel cell adhesion assay. It also increased the caspases 8 & 9 which are key regulators of apoptosis. Daidzin significantly decreased the expression of inflammatory gene and cell proliferating signaling molecule. To, conclude our results confirm daidzin effectively decreased inflammation and induced apoptosis in human cervical cancer HeLa cell line.

3.
Chaos ; 28(8): 083120, 2018 Aug.
Article in English | MEDLINE | ID: mdl-30180622

ABSTRACT

There is evidence that synaptic plasticity is a vital feature of realistic neuronal systems. This study, describing synaptic plasticity by a modified Oja learning rule, focuses on the effect of synapse learning rate on spike synchronization and its relative transitions in a Newman-Watts small-world neuronal network. The individual dynamics of each neuron is modeled by a simple Rulkov map that produces spiking behavior. Numerical results have indicated that large coupling can lead to a spatiotemporally synchronous pattern of spiking neurons; in addition, this kind of spike synchronization can emerge intermittently by turning information transmission delay between coupled neurons. Interestingly, with the advent of synaptic plasticity, spike synchronization is gradually destroyed by increasing synapse learning rate; moreover, the phenomenon of intermittent synchronization transitions becomes less and less obvious and it even disappears for relative larger learning rate. Further simulations confirm that spike synchronization as well as synchronization transitions is largely independent of network size. Meanwhile, we detect that large shortcuts probability can facilitate spike synchronization, but it is disadvantageous for delay-induced synchronization transitions.


Subject(s)
Models, Neurological , Nerve Net/physiology , Neuronal Plasticity/physiology , Neurons/physiology , Synaptic Transmission/physiology , Animals , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...